| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d93a6b9bb84835a244e4549a8abc358
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d24406cb2aba120d823c3abbf9c3952 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2009-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8edaa2dd4df2bb2f9aeea8b21b365db4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86bafb454d1321c82e66909ad0c9f2ac |
| publicationDate |
2010-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010008719-A9 |
| titleOfInvention |
Oral pharmaceutical formulations of vla-4 antagonists |
| abstract |
The present invention provides oral pharmaceutical formulations comprising a VLA-4 antagonist and a surfactant. In one preferred embodiment, the VLA-4 antagonist is the mono-sodium salt of (3S)-3-[({[1-(2-chlorobenzyl)-4-hydroxy-5-methyl-2-oxo-1,2-dihydropyridin-3-yl]amino}carbonyl)amino]-3-(4-methylphenyl)propanoic acid. The present invention also provides methods for treating and/or preventing and/or inhibiting progress of an inflammatory disease using such pharmaceutical formulations. |
| priorityDate |
2008-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |